BA/BE Studies

NoobTron Healthcare navigates the complexities of small molecule development from lead discovery to regulatory approval. By applying advanced methodologies and in-depth expertise, we deliver precise bioavailability and bioequivalence assessments that ensure your formulations meet regulatory expectations. Collaborating closely with you, we streamline development processes and shorten timelines, fast-tracking your progress from discovery through preclinical and clinical stages to market readiness.

Speak to Our Scientist

Bridge the Gap Between Science and Safety with NoobTron's Advanced Solutions

BA/BE Studies in Healthy Volunteers :

Leveraging one of the largest healthy volunteer databases and cutting-edge infrastructure across three clinical facilities, NoobTron delivers precise Pharmacokinetic (PK) and Pharmacodynamic (PD) studies. Trusted by leading regulatory bodies in the US and Europe, our studies adhere to the highest compliance standards, ensuring the accuracy of dosing, safety, and tolerability assessments. With expert execution, we provide reliable data that facilitates your drug’s progression while maintaining scientific rigor and regulatory adherence.

BA/BE Studies in Patients :

NoobTron’s extensive network of hospitals and investigators enhances our ability to perform PK/PD and clinical endpoint studies across diverse therapeutic areas. From oncology to psychiatry and dermatology, we prioritize patient eligibility and safety in every recruitment process. Our informed consent procedures guarantee that patients fully comprehend trial details while safeguarding their health and ensuring ethical conduct throughout the study.

Bioanalytcal Solutions :

At NoobTron, we utilize rigorously validated bioanalytical methods to ensure the accuracy, sensitivity, and specificity required for your Bioavailability (BA) and Bioequivalence (BE) studies studies. Our team of experts applies these methods to analyze samples with precision, providing critical data to evaluate the pharmacokinetic properties of your drug and support regulatory submissions, ensuring consistent, reliable results.

Complex Generics Development :

Navigating the complexities of generics development requires specialized knowledge and expertise. NoobTron’s scientists, with extensive experience and a deep understanding of advanced analytical techniques, are equipped to tackle the challenges of developing long-acting injectables and inhalation products. We ensure safety, efficacy, and bioequivalence in complex generics, delivering regulatory-compliant solutions that help maintain profitability and meet evolving market demands while adhering to tighter regulations.

Bioanalysis of Small Molecules & Generics

GLP-certified & GCP-compliant bioanalysis for preclinical, clinical, and bioequivalence studies NoobTron Healthcare delivers world-class small-molecule bioanalysis, providing rapid in vivo/in vitro ADMET screening, preclinical toxicokinetics, bioavailability and pharmacokinetic studies, drug–drug interaction assessments, and comprehensive clinical bioanalysis from Phase I–IV, including first-in-man and dose-escalation studies. As a GLP-certified, GCP-compliant multinational CRO, we support diverse client needs—from large generics companies requiring full bioequivalence programs, to biotech innovators advancing early-stage R&D, and animal health firms conducting regulatory residue depletion studies—ensuring precise, reliable, and regulatory-aligned bioanalytical outcomes.

Our catalog of services include

Preclinical small molecule studies
  • Pharmacokinetic, biomarker, pharmacodynamic, and toxicokinetic data analysis and modeling using advanced PK/PD software
  • Metabolite profiling including identification and quantification
  • Extensive experience with diverse animal models: rats, mice, rabbits, guinea pigs, cats, dogs, cattle, sheep, poultry.
  • Pharmacokinetics across all clinical phases, including first-in-human dose escalation protocols
  • Evaluation of drug-drug interactions
  • Biomarker detection and pharmacodynamic assessments
  • Full-spectrum bioequivalence studies aligned with international regulatory standards, collaborating with established European clinical centers
  • In vitro assessment of topical drug penetration and metabolism through human skin models and synthetic membranes
  • Management of preclinical studies with strategic partners covering animal housing and experimental design
  • Veterinary drug residue validation across complex biological matrices including liver, fat, muscle, brain, milk, honey, and eggs
  • Evaluation of dietary supplements and phytopharmaceutical absorption and effect profiles in vivo
  • Specialized bioanalytical method development for small molecules in complex matrices at low quantification limits with multiple analytes
  • Expertise in bioanalysis supporting clinical investigations of nutraceuticals, medical devices, and herbal formulations

One-stop solution for preclinical, clinical, and bioequivalence studies

NoobTron is fully coordinated with our alliance partners offering high-quality standards, narrow timelines, and competitive prices to provide a one-stop shop service in the following areas:

Residue depletion

  • Protocol writing
  • Submission to Ethics Committee and Regulators
  • Insurance contracting
  • Clinical center management and monitoring
  • Study execution
  • Sample shipment and storage

 STUDY REPORTING

  • (PK/PD) data analysis using industry-standard software
  • Pharmacokinetic report
  • Final clinical report
  • Specific reports to Authorities requests